Article and Video CATEGORIES

Cancer Journey

Search By

Dr. Jack West is a medical oncologist and thoracic oncology specialist who is the Founder and previously served as President & CEO, currently a member of the Board of Directors of the Global Resource for Advancing Cancer Education (GRACE)

 

New Podcast on Chemo-Induced Pneumonitis
Author
Howard (Jack) West, MD

Here's the beginning of a new podcast with my friend, Dr. Gerard Silvestri, who is a pulmonologist at the Medical University of South Carolina (MUSC) in Charleston.  He did a live webinar with us a few months ago, co-sponsored by GRACE and the LUNGevity Foundation, on the topic of pulmonary complications from lung cancer treatment, with the first part of his presentation focusing on chemotherapy-induced pneumonitis (lung inflammation), which we haven't spent a lot of time talking about.  

Here's the first podcast from his presentation, in both video and audio podcast formats, as well as the transcript and figures from the program.

Dr. Silvestri Pulm Complications LC Treatment Chemo Pneumonitis Audio Podcast

Dr. Silvestri Pulm Complications LC Treatment Chemo Pneumonitis Transcript

Dr. Silvestri Pulm Complications LC Treatment Chemo Pneumonitis Figs

We'll continue with further discussion of lung-related complications from treatment of lung cancer in the next podcast, which will cover targeted therapies.

Next Previous link

Previous PostNext Post

Related Content

Image
Videoteca de Cáncer de Pulmon - 2025
Video
Como parte de la Videoteca de Cáncer de Pulmón en Español 2025, oncólogos expertos discuten las opciones de tratamiento y la información más emergente en cáncer de pulmón. El Dr. Raez aborda la terapia para cánceres de pulmón EGFR y ALK, además de analizar otros tres temas de actualidad. La Dra. Viola y la Dra. Riaño también contribuyen a esta videoteca, cada una presentando tres temas relevantes sobre el cáncer de pulmón.
Article
The journey to conquer lung cancer is paved with scientific discovery, and the identification of the EGFR and ALK genes as crucial players marks a significant milestone. Unraveling how mutations in these seemingly small segments of our DNA can unleash the destructive force of cancer has opened up exciting new therapeutic avenues. This exploration delves into the cutting-edge world of EGFR and ALK-targeted therapies, highlighting the progress made and the ongoing quest for even more effective and personalized strategies to combat this formidable disease.
Image
Rare cancers
Video
In these videos,  Dr. Jared Weiss gives a brief overview of NUT Carcinoma, discusses treatment options and possible future treatment.  To watch the complete playlist, click here.